Katherine Bach Kalin - Aug 13, 2022 Form 4 Insider Report for SELLAS Life Sciences Group, Inc. (SLS)

Role
Director
Signature
/s/ Katherine Bach Kalin
Stock symbol
SLS
Transactions as of
Aug 13, 2022
Transactions value $
$0
Form type
4
Date filed
8/16/2022, 04:08 PM
Previous filing
Jun 15, 2021
Next filing
Feb 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLS Stock Option (Right to Buy) Award $0 +19K $0.00 19K Aug 13, 2022 Common Stock 19K $3.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will fully vest on August 13, 2023.